Nyxoah - Asset Resilience Ratio

Latest as of September 2025: 12.40%

Nyxoah (NYXH) has an Asset Resilience Ratio of 12.40% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

€11.61 Million

≈ $13.57 Million USD Cash + Short-term Investments

Total Assets

€93.60 Million

≈ $109.43 Million USD All company assets

Resilience Assessment

Moderate

Financial Resilience Level

Asset Resilience Ratio Trend (2021–2024)

This chart shows how Nyxoah's Asset Resilience Ratio has changed over time. Check strategic asset allocation of Nyxoah to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Nyxoah's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is Nyxoah worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	€0.00	0%
Short-term Investments	€11.61 Million	12.4%
Total Liquid Assets	€11.61 Million	12.40%

Asset Resilience Insights

Moderate Liquidity: Nyxoah has 12.40% of assets in liquid form.
While adequate for normal operations, this level may limit flexibility during economic stress.
The company has significant short-term investments, indicating active treasury management.

Nyxoah Industry Peers by Asset Resilience Ratio

Compare Nyxoah's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
BMC Medical Co. Ltd. A SHE:301367	Medical Instruments & Supplies	47.31%
Pegavision TW:6491	Medical Instruments & Supplies	17.14%
Nanosonics Ltd AU:NAN	Medical Instruments & Supplies	46.84%
SD Biosensor Inc KO:137310	Medical Instruments & Supplies	13.59%
Visco Vision Inc. TW:6782	Medical Instruments & Supplies	0.98%
Dentium KO:145720	Medical Instruments & Supplies	1.23%
Mark Dynamics Indonesia Tbk PT JK:MARK	Medical Instruments & Supplies	6.64%
Nissan TA:NISA	Medical Instruments & Supplies	0.58%

Annual Asset Resilience Ratio for Nyxoah (2021–2024)

The table below shows the annual Asset Resilience Ratio data for Nyxoah.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	32.43%	€51.37 Million ≈ $60.06 Million	€158.41 Million ≈ $185.19 Million	+3.32pp
2023-12-31	29.11%	€36.14 Million ≈ $42.25 Million	€124.16 Million ≈ $145.15 Million	-23.59pp
2022-12-31	52.69%	€76.97 Million ≈ $89.98 Million	€146.07 Million ≈ $170.77 Million	--
2021-12-31	0.00%	€0.00 ≈ $0.00	€170.83 Million ≈ $199.72 Million	--

pp = percentage points

About Nyxoah

BR:NYXH Belgium Medical Instruments & Supplies

Market Cap

$62.38 Million

€53.35 Million EUR

Market Cap Rank

#20917 Global

#91 in Belgium

Share Price

€1.24

Change (1 day)

-0.48%

52-Week Range

€1.24 - €7.28

All Time High

€29.90